Introduction In the light of the advances in HCV antiviral therapy, global control of HCV
infection becomes feasible but depends on the capacity of countries to identify infected …

The development of vaccines that protect against persistent hepatitis C virus (HCV) infection
remain a public health priority. The broad use of highly effective direct-acting antivirals …

Objectives To assess progress in Australia toward the 2030 WHO hepatitis C elimination
targets two years after the introduction of highly effective direct‐acting antiviral (DAA) …

The simplification of current hepatitis C diagnostic algorithms and the emergence of digital
diagnostic devices will be very crucial to achieving the WHO's set goals of hepatitis C …

Hepatitis C is a global health problem, with an estimated 71· 1 million individuals chronically
infected worldwide, accounting for 1%(95% uncertainty interval: 0.8–1.1) of the population …

Background & Aims Georgia, with a high prevalence of HCV infection, launched the world's
first national hepatitis C elimination program in April 2015. A key strategy is the identification …

Background Between May 2015 and February 2022, 77,168 hepatitis C virus (HCV)-infected
people in Georgia have been treated through an HCV elimination programme. To project the …

Abstract Background The country of Georgia launched the world's first Hepatitis C Virus
(HCV) Elimination Program in 2015 and set a 90% prevalence reduction goal for 2020. We …

Abstract The Spanish Association for the Study of the Liver (AEEH) is convinced that the
elimination of hepatitis C virus (HCV) in Spain is possible as long as we are able to use the …

WHO has set global targets for the elimination of hepatitis B and hepatitis C as a public
health threat by 2030. However, investment in elimination programmes remains low. To help …